Heart Failure
Devices

Learn more about the available heart failure technology from Abbott that may help extend and improve your quality of life.

Heart failure devices, know your options, improve your life

Learn About Common Heart Failure Devices

Device implantation such as a LVAD heart pump, pacemaker or pulmonary artery pressure monitor may be necessary to manage heart function and may prevent worsening heart failure. It's important to explore these options in advance so you can make informed decisions with your healthcare team if necessary. By understanding the risks and benefits, you'll feel more prepared and confident in your treatment plan.

CardioMEMS HF System - Remote Pulmonary Artery Pressure Monitoring for Proactive Heart Failure Management

CardioMEMS – Remote Pulmonary Artery Pressure Monitoring for Proactive Heart Failure Management

The CardioMEMS™ HF System is a small, wireless sensor placed in the pulmonary artery to monitor pressure and detect early signs of worsening heart failure. It allows you and your healthcare providers to monitor pulmonary artery pressure remotely and make timely adjustments to medications or treatment plans. This proactive approach helps prevent hospitalizations1 and improves overall management of heart failure. For patients, the CardioMEMS HF System offers the benefit of more precise, personalized care, leading to better outcomes and a higher quality of life.

Introduction to the CardioMEMS HF System
Watch Cynthia’s Story with Heart Failure

HeartMate 3 LVAD - A Heart Pump for People with Advanced Heart Failure

An LVAD Blood Pump – A Lifechanging Option for Advanced Heart Failure

An LVAD (Left Ventricular Assist Device) is a mechanical blood pump that helps pump blood through the body when the heart is no longer strong enough to.  It can be used either short or long-term support and serve as a bridge to heart transplantation. The device is implanted surgically and works by taking over the pumping function of the weakened heart. The HeartMate 3™ LVAD can help improve symptoms, extend survival, and enhance quality of life.2,3


Associated risk of LVAD therapy can include bleeding, stroke, thrombosis and other possible adverse events.

Watch How an LVAD Blood Pump Works
See How an LVAD Gave Dennis, an Advanced Heart Failure Patient, More Quality Time

Cardiac Resynchronization Therapy (CRT)

A CRT-D and CRT-P are devices that correct irregular heartbeats, whether they are too fast, slow or out of sync by sending electrical signals to help maintain a steady heart rate. It is used when the heart's natural electrical system is not functioning properly.

Cardiac Resynchronization Therapy (CRT) – Helping to Keep Your Heart’s Rhythm

Implantable Cardioverter Defibrillator (ICD)

An Implantable Cardioverter Defibrillator (ICD) is a small device implanted in the chest to monitor heart rhythms and prevent sudden cardiac arrest in patients with heart failure or arrhythmias. If it detects a dangerous, irregular heartbeat, the ICD delivers electrical shocks to restore normal heart rhythm, reducing the risk of life-threatening complications. It is commonly used in heart failure patients who are at high risk for ventricular arrhythmias.

Implantable Cardioverter Defibrillator (ICD)

Would you like to connect with other people with heart failure? 

Sign up today to speak with other people with heart failure.

Connect with heart failure patients and find support by joining the Ambassador program today.

These materials are not intended to replace your doctor's advice or information. For any questions or concerns you may have regarding the medical procedures, devices and/or your personal health.

 

References:

  1. Abraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M. F., Costanzo, M. R., Stevenson, L. W., … Yaday, J. S. (2011). Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. The Lancet, 377(9766), 658-666. n=550. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60101-3/fulltext
  2. Mehra MR, Goldstein DJ, Cleveland JC, et al. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. September 8, 2022. doi:10.1001/jama.2022.16197
  3. Schmitto JD, Shaw S, Garbade J, et al. Long-Term Results in Real World Patients Treated with HeartMate 3 LVAD for Advanced Heart Failure: Data from the ELEVATE Registry. European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting; October 8, 2022; Milan, Italy.

MAT-2415417 v1.0